163 results on '"Pisters L"'
Search Results
2. Validation of a blood-based sphingolipid panel for men with prostate cancer on active surveillance
3. Post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer at a national referral center
4. Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer
5. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer
6. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders
7. O11 - Post-chemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer at a national referral center
8. Health Behaviors and Depressive Symptoms in Testicular Cancer Survivors
9. Outcomes of men with ductal prostate cancer undergoing definitive therapy for localized disease
10. Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone
11. Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer
12. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders
13. Clinical Trial Enrollment in a Multidisciplinary Prostate Cancer Clinic
14. Prostate Cancer Treatment Selection after Counseling in a Multidisciplinary Prostate Cancer Clinic
15. MP-15.18 Long-Standing Hydrocele in Adult Black Africans: Is Automatic Ordering of Pre-operative Scrotal Ultrasound Justified?
16. Presurgical docetaxel (Doc) and androgen deprivation therapy (ADT) in lymph node-positive prostate cancer (PCa).
17. POD-5.08: Active Surveillance for Clinically-Localized Prostate Cancer at a High Volume Tertiary Referral Center
18. Presurgical sunitinib malate and androgen ablation in patients with localized prostate cancer at high risk for recurrence
19. Long-term effects of pre-surgical stress management for men with early stage prostate cancer undergoing radical prostatectomy (RP)
20. Differential gene expression in preoperative study of selenium and vitamin E chemoprevention in prostate cancer
21. Preoperative platelet-derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation in high-risk localized prostate cancer
22. Initial Modulation of the Tumor Microenvironment Accounts for Thalidomide Activity in Prostate Cancer
23. A preoperative model evaluating the tissue effects of chemopreventive agents in low-volume prostate cancer
24. Predictors of survival in patients undergoing post-chemotherapy retroperitoneal lymph node dissection
25. Neoadjuvant Hormone Therapy (NHT) Leads to Immediate Impairment of Vitality/Hormonal and Sexual Quality of Life: Results of a Multi-Center Prospective Study
26. The dose response characteristics of low and intermediate risk prostate cancer treated with external beam radiotherapy
27. Salvage radical prostatectomy: Refinement of an effective procedure
28. Assessment of biochemical disease free progression in men with prostate cancer younger than 60 years of age :MD Anderson experience
29. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy.
30. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
31. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
32. Bropirimine Immunotherapy of Upper Urinary Tract Carcinoma in Situ
33. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy
34. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy
35. Pubourethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence.
36. 705P Subsequent malignant neoplasms (SMN) in patients with germ cell tumor of the testis (TGCT): Implications on a genetic vs stem cell origin of cancers.
37. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results.
38. Effect of prior therapy on survival after salvage cryotherapy for recurrent prostate cancer.
39. A comparison of biochemical outcome following salvage prostatectomy or cryosurgery for locally recurrent prostate cancer after radiation therapy
40. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer
41. Use of Predeposit Autologous Blood and Intraoperative Autotransfusion in Urologic Cancer Surgery
42. P236 - Validation of a blood-based sphingolipid panel for men with prostate cancer on active surveillance.
43. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer
44. In response to Drs. Lawrence and Crawford
45. The association of body mass index with tumor aggression among men undergoing radical prostatectomy.
46. Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy: Complications and Outcomes From a Comprehensive Cancer Center.
47. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers.
48. Optimizing the diagnosis and management of ductal prostate cancer.
49. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies.
50. Adverse effects of androgen deprivation therapy in patients with prostate cancer: Focus on muscle and bone health.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.